Risk prediction for patients with cardiovascular diseases
"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease" ("riskINN ")
This study is trying to create a way to identify adults with heart problems who are at high risk for serious issues, so they can get help sooner.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University Innsbruck Academic / other |
| Locations | 2 sites (Innsbruck, Tyrol and 1 other locations) |
| Trial ID | NCT05472207 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop risk prediction models to identify high-risk patients suffering from structural, rhythmological, or inflammatory cardiovascular diseases. By analyzing various factors, the study seeks to enhance early detection and stratification of patients based on their risk levels. The study will include decision-eligible adults aged 18 and older who provide informed consent for participation.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with acute or chronic cardiovascular conditions.
Not a fit: Patients who are pregnant or breastfeeding, or those unable to provide informed consent, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of high-risk cardiovascular patients.
How similar studies have performed: While similar studies have explored risk stratification in cardiovascular diseases, this specific multifactorial approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Decision-eligible male and female patients ≥18 years of age * Acute or chronic condition due to structural, rhythmologic, or inflammatory cardiovascular disease * Informed consent for participation in the clinical trial Exclusion Criteria: * missing infromed consent * pregnant or breast-feeding women
Where this trial is running
Innsbruck, Tyrol and 1 other locations
- Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III, Kardiologie & Angiologie — Innsbruck, Tyrol, Austria (Recruiting)
- Reha Zentrum Münster — Münster, Tyrol, Austria (Recruiting)
Study contacts
- Study coordinator: Axel Bauer, Univ.-Prof. Dr.
- Email: axel.bauer@i-med.ac.at
- Phone: +43 512 504 25621
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.